Pharmacokinetics, biodistribution and brain retention of a bispecific antibody-based PET radioligand for imaging of amyloid-β
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacokinetics, biodistribution and brain retention of a bispecific antibody-based PET radioligand for imaging of amyloid-β
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-12-04
DOI
10.1038/s41598-017-17358-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A bispecific Tribody PET radioligand for visualization of amyloid-beta protofibrils – a new concept for neuroimaging
- (2017) Stina Syvänen et al. NEUROIMAGE
- Bivalent Brain Shuttle Increases Antibody Uptake by Monovalent Binding to the Transferrin Receptor
- (2017) Greta Hultqvist et al. Theranostics
- Antibody-based PET imaging of amyloid beta in mouse models of Alzheimer’s disease
- (2016) Dag Sehlin et al. Nature Communications
- Soluble Amyloid-beta Aggregates from Human Alzheimer’s Disease Brains
- (2016) Thomas J. Esparza et al. Scientific Reports
- Prevalence of Amyloid PET Positivity in Dementia Syndromes
- (2015) Rik Ossenkoppele et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cross-Sectional Comparison of Small Animal [18F]-Florbetaben Amyloid-PET between Transgenic AD Mouse Models
- (2015) Matthias Brendel et al. PLoS One
- Increased Brain Penetration and Potency of a Therapeutic Antibody Using a Monovalent Molecular Shuttle
- (2014) Jens Niewoehner et al. NEURON
- Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates
- (2014) Y. J. Yu et al. Science Translational Medicine
- Perspectives on future Alzheimer therapies: amyloid-β protofibrils - a new target for immunotherapy with BAN2401 in Alzheimer’s disease
- (2014) Lars Lannfelt et al. Alzheimers Research & Therapy
- Longitudinal Amyloid Imaging in Mouse Brain with 11C-PIB: Comparison of APP23, Tg2576, and APPswe-PS1dE9 Mouse Models of Alzheimer Disease
- (2013) A. Snellman et al. JOURNAL OF NUCLEAR MEDICINE
- Brainwide distribution and variance of amyloid-beta deposits in tg-ArcSwe mice
- (2013) Sveinung Lillehaug et al. NEUROBIOLOGY OF AGING
- Amyloid-beta oligomerization in Alzheimer dementia versus high-pathology controls
- (2012) Thomas J. Esparza et al. ANNALS OF NEUROLOGY
- Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers
- (2012) M. Scholl et al. NEUROLOGY
- Large Aggregates Are the Major Soluble Aβ Species in AD Brain Fractionated with Density Gradient Ultracentrifugation
- (2012) Dag Sehlin et al. PLoS One
- Observations in APP Bitransgenic Mice Suggest that Diffuse and Compact Plaques Form via Independent Processes in Alzheimer's Disease
- (2011) Anna Lord et al. AMERICAN JOURNAL OF PATHOLOGY
- High-molecular-weight β-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients
- (2010) Hiroaki Fukumoto et al. FASEB JOURNAL
- Animal models of amyloid-β-related pathologies in Alzheimer’s disease
- (2010) Ola Philipson et al. FEBS Journal
- Limitations of Small Animal PET Imaging with [18F]FDDNP and FDG for Quantitative Studies in a Transgenic Mouse Model of Alzheimer’s Disease
- (2009) Claudia Kuntner et al. MOLECULAR IMAGING AND BIOLOGY
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
- (2008) Ganesh M Shankar et al. NATURE MEDICINE
- A highly insoluble state of Aβ similar to that of Alzheimer's disease brain is found in Arctic APP transgenic mice
- (2008) Ola Philipson et al. NEUROBIOLOGY OF AGING
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started